
Overview
Status
Active
Registry date
2007-08-09
Share capital
50,000.00 PLN
Activity description
Biofar is a pharmaceutical company founded in 2009 and part of a family group with 25 years of experience in the medical, pharmaceutical and aesthetic medicine sectors. It supplies hospitals and medical facilities across the country with biological, oncology, cardiology, antibiotic, antifungal and gastroenterology preparations.
Financials
Only balance sheet data (assets and liabilities) is available. The income statement (P&L) is not available in the source filing for this period.
Revenue history
Filing timeliness
Financial statements were filed on time, on average 39 days early.
- 202527/06/2026
- 202428/06/2025
- 202328/05/2024
- 202226/06/2023
- 202121/06/2022
- 202030/06/2021
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Industry
Offer
- Biological preparations
- Oncology preparations
- Cardiological preparations
- Antibiotics
- Antifungal medicines
- Gastroenterological preparations
Authorized Representatives
Jakub Konrad Krochmalski – President of the Management Board
Roman Paweł Mamrot – Vice President of the Management Board
Manner of representation
Each member of the management board represents the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Jakub Konrad Krochmalskiage 50 | 50 | $6,753.11 | 50% |
Roman Paweł Mamrotage 53 | 50 | $135.06 | 1% |
Others | 96 | $6,618.04 | 49% |
Beneficial owners
| Person | Rights |
|---|---|
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Polska Grupa FarmaceutycznaS.A. | $1,778,266,449.02 | pgf.com.pl | ||
| Delfarmasp. z o.o. | $63,830,205.42 | delfarma.pl | ||
| Farmbudsp. z o.o. | $2,476,637.88 | farmbud.eu | ||
| Celltrion Polandsp. z o.o. | $1,237,076.36 | celltrion.pl | ||
| Mediationsp. z o.o. | $835,285.09 | mediation.pl | ||
| PharmenaS.A. | $541,436.46 | pharmena.eu | ||
| Apteczka Pacjentasp. z o.o. | $30,042.28 | apteczkapacjenta.pl | ||
| Edge Pharmasp. z o.o. | $19,855.64 | edgepharma.eu | ||
| Biofarsp. k. | $12,405.22 | biofar.pl | ||
| Endolink PharmaS.A. | $5,022.60 | endolink.pl |
Change history
| Date | Event | |
|---|---|---|
| 2019-06-13 | Name change (Medica Magnus → Biofar Spółka Z Ograniczoną Odpowiezialnością) | |
| 2019-06-13 | Switch to PKD 2007 (148 PKD 2004 codes → 10 PKD 2007 codes) | |
| 2007-08-09 | Entered in the register |
FAQ
The main business activity of Biofar focuses on wholesale of pharmaceutical goods.
The company was registered in the Polish National Court Register (KRS) on August 9, 2007.
The headquarters is located at: Kopernika 38, 90-552 Łódź.
The management board includes Jakub Konrad Krochmalski (President of the Management Board).
The share capital of the company is PLN 50,000 (approx. $13,506).
The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.
Last updated: 2026-09-30